Sinovac Biotech Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SVA research report →
About the company
Sinovac Biotech Ltd. is a biopharmaceutical firm primarily dedicated to the discovery, research, manufacturing, and sales of vaccines aimed at combating infectious human diseases across the People's Republic of China. Its extensive product range encompasses immunizations against Hepatitis A and B; hand, foot, and mouth disease caused by Enterovirus 71 (EV71); seasonal influenza; H5N1 and H1N1 pandemic influenza strains; coronavirus; varicella (chickenpox); and mumps.
- CEO
- Wei Dong Yin
- IPO
- 2003
- Employees
- 1,959
- HQ
- Beijing, CN
Price Chart
- Market Cap
- $464.94M
- P/E
- -7.80
- P/S
- 1.20
- P/B
- 0.10
- EV/EBITDA
- 0.98
- Div Yield
- 850.08%
- Gross Margin
- 67.87%
- Op Margin
- -75.47%
- Net Margin
- -15.46%
- ROE
- -0.91%
- ROIC
- -3.02%
- Revenue
- $386.01M · 0.00%
- Net Income
- $-59,680,000 · 0.00%
- EPS
- $-0.83 · 0.00%
- Op Income
- $-291,322,000
- FCF YoY
- 0.00%
- 52W High
- $6.47
- 52W Low
- $6.47
- 50D MA
- $6.47
- 200D MA
- $6.47
- Beta
- 0.00
- Avg Volume
- 0
Get TickerSpark's AI analysis on SVA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 17, 26 | Li Jiaqiang | other | 0 |
| Mar 18, 26 | LI JING (NMN) | other | 0 |
| Mar 18, 26 | Yang Guang (Helen) | other | 0 |
| Mar 18, 26 | GAO QIANG (NMN) | other | 0 |
| Mar 18, 26 | WANG NAN | other | 0 |
| Mar 18, 26 | WANG YU (NMN) | other | 0 |
| Mar 18, 26 | JIAO SHUGE | other | 0 |
| Mar 18, 26 | LO YUK LAM | other | 0 |
| Mar 18, 26 | QIU YU MIN | other | 0 |
| Mar 18, 26 | Yan Andrew Y | other | 0 |
Our SVA coverage
Recent articles, reports, and earnings notes.
No research on SVA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SVA report →Similar companies
Peers in the same neighborhood.